Cargando…

Polymyxin B Hemoperfusion in Pediatric Septic Shock: Single-Center Observational Case Series

To evaluate the use of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) as adjunctive therapy during pediatric patients with septic shock. DESIGN: Prospective observational study. SETTING: Nine-bed PICUs at university referral hospital. PATIENTS: Children (30 d to 15 yr) with septic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saetang, Patcharin, Samransamruajkit, Rujipat, Singjam, Kanokwan, Deekajorndech, Tawatchai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Online Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345520/ https://www.ncbi.nlm.nih.gov/pubmed/35687100 http://dx.doi.org/10.1097/PCC.0000000000002969

Ejemplares similares

Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis
por: Chang, Tzu, et al.
Publicado: (2017)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock
por: Kim, Jin Joo, et al.
Publicado: (2019)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion
por: Sekino, Motohiro, et al.
Publicado: (2023)

278. Effects of polymyxin B direct hemoperfusion by measurement of outer membrane vesicles in patients with septic shock
por: Min Jo, Kyeong
Publicado: (2023)

Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2016)

Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database
por: Fujimori, Kenji, et al.
Publicado: (2023)

“Impact of timing of polymyxin B‐immobilized fiber column direct hemoperfusion on outcome in patients with septic shock: a single‐center observational study”
por: Tanaka, Tomoki, et al.
Publicado: (2019)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study
por: Nakamura, Yoshihiko, et al.
Publicado: (2017)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock
por: Kim, Young A, et al.
Publicado: (2019)

Mortality Risk Prediction in Abdominal Septic Shock Treated with Polymyxin-B Hemoperfusion: A Retrospective Cohort Study
por: Garcia-Ramos, Sergio, et al.
Publicado: (2023)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Polymyxin B-direct hemoperfusion therapy contributes to oxygen delivery in septic patients
por: Yaguchi, A, et al.
Publicado: (2012)

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
por: Payen, Didier M., et al.
Publicado: (2015)

Balanced Salt Solution Versus Normal Saline in Resuscitation of Pediatric Sepsis: A Randomized, Controlled Trial
por: Trepatchayakorn, Sirawut, et al.
Publicado: (2021)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum
por: Kodama, Yoshiyuki, et al.
Publicado: (2019)

Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial
por: Klein, D. J., et al.
Publicado: (2018)

Polymyxin B hemoperfusion: a mechanistic perspective
por: Ronco, Claudio, et al.
Publicado: (2014)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series
por: Forfori, Francesco, et al.
Publicado: (2018)

Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2020)

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors
por: Cantaluppi, Vincenzo, et al.
Publicado: (2008)

Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study
por: Matsukuma, Satoshi, et al.
Publicado: (2015)

The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis
por: De Rosa, Silvia, et al.
Publicado: (2019)

Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors
por: Chanakul, Ankanee, et al.
Publicado: (2021)

The Utilization of the Surviving Sepsis Campaign Care Bundles in the Treatment of Pediatric Patients with Severe Sepsis or Septic Shock in a Resource-Limited Environment: A Prospective Multicenter Trial
por: Samransamruajkit, Rujipat, et al.
Publicado: (2018)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
por: Navas, Ana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e8b0lv2tkurvbq7uvgtssufnvj